At the 14th day, 39% of cases belonging to the polyglactin 910 group presented young fibroblasts Figure 12; SNT Figure 11 and B-CAC Figure 13 represented 33 and 28% of cases respectively.
Al 14° día, el 39% de los casos correspondientes al grupo de poliglactina 910, presentaban fibroblastos jóvenes Figura 12, la SNT Figura 11 y el CAC-B Figura 13 representaron el 33% y 28% de los casos respectivamente.